A phase I, dosage-finding and pharmacokinetic study of intravenous topotecan and oral erlotinib in adults with refractory solid tumors.
Phase of Trial: Phase I
Latest Information Update: 26 Nov 2014
At a glance
- Drugs Erlotinib (Primary) ; Topotecan (Primary)
- Indications Solid tumours
- Focus Adverse reactions; Pharmacokinetics
- 31 Aug 2018 Biomarkers information updated
- 17 Feb 2010 Actual patient number (29) added as reported by ClinicalTrials.gov.
- 16 Sep 2009 Actual end date (Jun 2009) added as reported by ClinicalTrials.gov.